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Abstract: The present study evaluated the expression of secretory proteins involving surfactant proteins (SP-A, SP-B, proSP-C), Clara
cell secretory protein (CCSP), and thyroid transcription factor-I (TTF-I), together with lambda light chain IgG (λ-IgG), proliferating
cell nuclear antigen (PCNA), and lymphocytic phenotypes (T and B cells) in the pneumonic rat lungs. The most prominent gross
lesion was severe pulmonary abscession. The lungs showed severe parenchymal destruction and necrosis encapsulated by fibrous tissue.
Immunostaining for SPs displayed evident hyperplasia of type II pneumocytes. Immunoreaction to SP-A and SP-B occurred strongly
on the luminal surface of type II cells, and to proSP-C in the perinuclear area. CCSP immunolabeling was seen in the cytoplasm of the
lining epithelium of the distal airways. The nuclei of type II cells labeled positively for TTF-I. The λ-IgG positive reaction was found in
the cytoplasm of plasmacytes and B cells. PCNA staining confirmed proliferation of type II cells and fibroblasts. Moderate numbers of
CD3+ T cells, but few CD79αcy+ B cells, were found in the lungs. Statistical analysis found high significance (P < 0.001, except for λ-IgG)
between groups. The results of the study revealed that type II cells proliferate highly to restore the damaged lungs and that CCSP and
SPs may be used to identify tumors originating from Clara cells and type II pneumocytes of rats, respectively.
Key words: Immunohistochemistry, lungs, pneumonia, rat, secretory proteins

1. Introduction
Diseases of the respiratory tract are the most common
health problems in rats and mice kept in laboratories. Such
laboratory animals are often exposed to unconventional
storage conditions and therefore often develop acute
or chronic pneumonia, and a variety of bacteria may be
isolated from the lungs of affected rats. As is the case
in other mammalian species, bacteria are generally
believed to be secondary invaders of infected lungs (1).
Numerous specific microbial agents, pathogenicity of
which might be varied, have been recognized as important
respiratory pathogens of laboratory rats and mice.
Additionally, subclinical infections are far more common
than overt diseases for all of the agents. It has been well
documented that in laboratory rats pneumonia is often
seen in the chronic form of the disease and that the agents
involved are often Mycoplasma pulmonis, Streptococcus
pneumoniae, Pneumocystis carinii, Klepsiella pneumoniae,
Mycoplasma collis, Sendai virus and rat coronavirus (1).
Severe natural respiratory diseases in rats are caused by M.
pulmonis in combination with Sendai virus. M. pulmonis
is an extracellular species of bacteria that preferentially
localizes on the luminal surface of epithelium in the
upper respiratory tract of rats, while Sendai virus is very

important in mice (1). Characteristic pathologic lesions
may occur at any level of the respiratory tract and include
laryngitis, tracheitis, bronchiectasis, pulmonary abscesses,
mucosal hyperplasia, and lymphoid infiltration in the
lung parenchyma. In particular, hyperplastic bronchusassociated lymphoid tissue (BALT) is an important lesion
of the lungs in rats with respiratory mycoplasmosis and
has been reported to be related to a potent nonspecific
antigenic stimulation of M. pulmonis. The alveolar lumina
of a mammalian lung are lined by alveolar epithelial cells
designated as type I and type II pneumocytes. In mature
lungs, most of the alveolar lumina are lined by type I cells
and constitute a huge amount of the alveoli allowing the
exchange of gas between the alveolar surface and capillary
vessels in the alveolar septum (2).
Type II alveolar epithelial cells are the progenitors for
type I cells and have important functions in the restoration
of injured lungs (2–6). Pulmonary surfactant apoproteins
(SPs) are an important component of the alveolar lining
layer and are secreted by the epithelial type II cells and
nonciliated Clara cells in distal terminal bronchi. The most
crucial function of SPs is to diminish the surface tension
at the alveoli and thus to prevent alveolar collapse at
end-expiration (7). Lung surfactant is a complex mixture
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consisting of approximately 10% proteins and 90% lipids.
To date, four surfactant apoproteins have been described as
SP-A, SP-B, SP-C, and SP-D (4,7,8). Lung secretory proteins
expressed by the distal airways and lining epithelial cells
of alveoli have been stated to prevent the aggregation of
infiltrative cells and the production of collagenous tissue in
the lung. Nonciliated Clara cells constitute high numbers
of coated cells in the distal conducting airways and they
are progenitors for ciliated lining cells in the airways.
CCSP is one of the important proteins expressed by Clara
cells in the distal airways and is thought to interfere with
inflammation and fibrosis in the lungs (9,10). TTF-I is a
nuclear protein secreted in the lung epithelium, thyroid
tissue, and in the restricted areas of the brain. TTF-I is
synthesized by type II epithelial and Clara cells of the
lungs and has an important function in the regulation
of surfactant apoproteins and CCSP (11). TTF-I has also
been often used to establish the origin of tumors from the
thyroid and the lungs (12). It is well known that diseases of
the respiratory tract in laboratory rats and mice are among
the most common health problems. However, to date, only
a few studies have been published on the expression of
secretory proteins in the lungs of laboratory rats. Thus, this
study aimed to examine the expression of lung secretory
proteins (SP-A, SP-B, proSP-C, CCSP, TTF-I), λ-IgG,
PCNA, and lymphocytic phenotypes (T and B cells) by
histopathology of the pneumonic lungs of rats.
2. Materials and methods
2.1. Animals and histopathology
Fifteen pneumonic lungs of laboratory rats, submitted for
necropsy from preexperimental studies, and five normal
lungs, which were supplied from previous studies, were
used in this research. Fixation of all the lung specimens,
following necropsy, was performed using a 10% formalin
solution. Serial lung slides of 5 µm thickness were taken

from the routinely-processed paraffin blocks, stained with
hematoxylin and eosin (H&E), and examined under a light
microscope.
2.2. Immunohistochemistry
A standard avidin-biotin-peroxidase complex (ABC)
technique (13) was performed to examine the expression of
lung secretory proteins involving surfactant proteins (SPA, SP-B, proSP-C), Clara cell secretory protein (CCSP),
and thyroid transcription factor-I (TTF-I) associated
with the lambda light chain IgG (λ-IgG), proliferating cell
nuclear antigen (PCNA), and lymphocytic phenotypes
(CD3+ T and CD79αcy+ B cells). Table 1 shows details of
the primary antibodies used. All paraffin sections were
deparaffinized in xylene and hydrated through graded
alcohol series. To block endogenous peroxidase activity,
all sections were incubated in 3% H2O2 solution for 20
min. For antigen retrieval, the paraffin slides were boiled
in citrate buffer saline (pH 6.0) in a microwave oven for
20 min. To prevent background staining, all slides were
incubated with 10% normal goat serum (SP-A, SP-B,
proSP-C, CCSP, TTF-I, λ-IgG) or normal rabbit serum
(PCNA, CD79αcy) for 60 min at room temperature
(RT). Then, the slides were incubated with the primary
antibodies overnight at 4–6 °C. The slides were treated
with biotinylated goat antirabbit IgG (SP-A, SP-B, proSP-C,
CCSP, TTF-I, λ-IgG) and biotinylated rabbit antimouse
IgG (PCNA, CD79αcy), supplied by DAKO (Carpinteria,
CA, USA) at a dilution of 1/200 in tris-buffered saline
(TBS, pH 7.6) for 60 min at RT. Then, all slides were
incubated with streptavidin-peroxidase complex (DAKO,
Carpinteria, CA, USA) at a dilution of 1/300 for 30 min at
RT. All sections were rinsed three times with TBS for 5 min
in each step, with the exception of the primary antibody
incubation. Polyclonal rabbit antihuman CD3 antibody
and LSAB2 system staining (DAKO, Carpinteria, CA,
USA) was performed to differentiate T lymphocytes. For

Table 1. Antibodies used for immunohistochemical staining of pneumonic rat lungs.
Primary antibody

Pretreatment

Polyclonal rabbit antibovine SP-A

Microwave oven

Dilution

Incubation
conditions

Origin (commercial
reference)

1 in 1000

Overnight at 4 °C

Chemicon (AB3424)

Polyclonal rabbit antisheep SP-B

Microwave oven

1 in 2000

Overnight at 4 °C

Chemicon (AB3780)

Polyclonal rabbit antiproSP-C

Microwave oven

1 in 500

Overnight at 4 °C

GeneTex (GTX 15012)

Polyclonal rabbit antihuman CCSP

Microwave oven

1 in 150

Overnight at 4 °C

Upstate (07-623)

Polyclonal rabbit antihuman TTF-I

Microwave oven

1 in 1000

Overnight at 4 °C

Seven Hill Bioreagents (WRAB-TTF1)

Polyclonal rabbit antihuman λ-IgG

Microwave oven

1 in 1500

Overnight at 4 °C

Novocastra (NCL-AMP)

Polyclonal rabbit anti-CD3

Microwave oven

1 in 150

Room temperature

Dako (Code: N1580)

Monoclonal mouse antihuman CD79cy

Microwave oven

1 in 50

Room temperature

Dako (Clone: HM57)

Monoclonal mouse anti-PCNA

Microwave oven

1 in 2000

Overnight at 4 °C

Chemicon (Clone PC10)
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immune labeling of the slides, both 3,3 diaminobenzidine
(DAB) and 3-amino-9-ethylcarbazole (AEC) were used
as the chromogen. Mayer’s hematoxylin was used as the
counterstain. Primary antibodies were removed from the
negative control sections and were treated with diluted
normal goat or rabbit serum. Mean numbers of the cells
immunolabeled with the antibodies (except for CD3 and
CD79cy) were counted in three representative fields from
each case using a 40× objective of a light microscope.
2.3. Statistical analysis
Variables in the counted cells in the control and
pneumonic lung sections that were immunostained with
the antibodies (SP-A, SP-B, SP-C, CCSP, TTF-I, PCNA,
λ-IgG) and showed cytoplasmic or nuclear staining were
evaluated. Statistical analysis was performed using SPSS
software version 18 (SPSS Inc, Chicago, IL, USA) by using
one-way ANOVA test for mean values. A P value less than
0.05 was considered statistically significant.
3. Findings
3.1. Gross findings
The most characteristic lesion in the lungs of rats was severe
pulmonary abscession (Figure 1), which was detected
in the lungs of nine rats. Lung abscesses were multiple
and commonly circumscribed by a fibrous capsule. In
some rats, the lung abscesses were fluid in character
and grayish in color, and in others, they were thick. The
abscessed lungs were clearly seen to be sticking to the ribs
and pericardial sacs. The pneumonic lungs commonly
revealed red consolidation and fibrinopurulent pleuritis,
associated with a mottled appearance or interspersed with
multiple grayish foci of severely increased firmness. Some
abscessed lungs also showed necrosis, hemorrhages, and
pleural thickening. The lungs with interstitial pneumonia
had a mottled appearance and slight consolidation. The
control rat lungs did not show any lesion in the lung lobes.
3.2. Histopathological findings
The abscessed lungs showed severe destruction of the
pulmonary parenchyma and were surrounded by fibrous
tissue within the lung parenchyma (Figure 2). Bacterial
masses and calcified material were often detected within
the center of the abscesses. The lung parenchyma was
commonly collapsed because of the interalveolar septal
hyperemia and increased connective tissue, and all alveoli
were filled with alveolar macrophages which were seen to
engulf pigment particles. In one rat, a parasite was found
in the lung, along with severe abscession characterized
by diffuse fibrosis of alveolar septum. The alveoli around
the parasite revealed severe edema, diffuse eosinophil
infiltration, focal neutrophil aggregation, and high
proliferation of type II cells. Proliferated type II cells were
generally of glandular appearance and were formed of
round and vesicular nuclei with single nucleoli. The cases
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Figure 1. Pus formation in the lung lobes of a rat.

Figure 2. Purulent bronchopneumonia characterized by severe
neutrophilic aggregation in the pulmonary parenchyma (H&E,
Bar = 543 µm).

with chronic purulent pneumonia showed severe necroses
associated with neutrophilic aggregations and surrounded
by a widespread fibrotic response causing displacement of
the parenchyma. In some areas, alveolar lumina had severe
plasmacytic infiltration and multiple Russell’s bodies.
The lungs with interstitial pneumonia (5 cases) revealed
a diffuse interalveolar septal thickening caused by severe
mononuclear cell infiltration and septal hyperemia, and
many lymphoid follicle formations around the conducting
airways. The thickened alveolar septum also showed clear
hyperplasia of type II pneumocytes.
3.3. Immunohistochemical findings
3.3.1. Surfactant apoproteins (SP-A, SP-B, proSP-C)
In the abscessed lungs, SP-A immunoreaction was
detected in the cytoplasm of type II pneumocytes or
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as a thin line within the alveolar lumina (Figure 3),
predominantly in the proliferative lung parenchyma. In
the lung parenchyma showing diffuse fibrosis, numerous
type II cells revealed a severe cytoplasmic reaction.
Cytoplasmic immunoreaction was evidently granular in
appearance, displaying proliferation of type II cells, and
immunostaining occurred mainly in the apical surface
of the cells. Immunostaining for SP-B clearly identified
type II cells arranged around the alveolar lumina in the
interalveolar septum. The cells had round nuclei and
immunoreaction products of a rough granular appearance
were commonly seen at the apical surface of the cells. The
number of SP-B–immunopositive type II pneumocytes
was increased in the thickened alveolar septum and
around the pneumonic areas (Figure 4). Type II cells
which proliferated with a glandular appearance in H&Estained sections showed a dense cytoplasmic staining for
SP-B and the number of positive cells was uncountable in
the pneumonic parenchyma characterized by increased
connective tissue and infiltrative mononuclear cells.
However, immunolabeling appearing as a thin layer in
alveoli for SP-A did not occur for SP-B. In some lungs
with alveolar edema, SP-B immunostaining displayed a
few type II pneumocytes within the fluid. The number of
SP-B–immunopositive type II cells was evidently increased
and immunopositive granules were seen to surround the
nuclei and their number was increased in the cytoplasm
of the proliferated cells. In addition to type II cells, in
some terminal bronchioles, the lining epithelium showed
immunopositivity for SP-B. ProSP-C immunoreaction was
found in all type II cells, as in SP-A and SP-B stainings.
Even though proSP-C immunoreaction was seen in all
of the cytoplasm, an intense staining occurred around
the nuclei of type II cells (Figure 5). ProSPC reactive
cells were generally seen in the interalveolar regions;
however, huge numbers of the cells were found around
the peribronchiolar areas or within the pneumonic areas.
Type II cells were frequently found at the corner of alveoli
and at the extensions of interlobular septum. In the
peribronchiolar regions, a few proliferated type II cells of
tubular appearance were found, and lymphoid infiltrations
were surrounded by high numbers of type II cells, showing
a strong perinuclear immunoreactivity. In the alveoli
with edema, proSP-C immunoreaction clearly displayed
type II cells. In the edema fluid, small extracellular
immunoreactive foci were infrequently seen.
In the lungs with interstitial pneumonia,
immunostaining for the surfactant apoproteins displayed
an evident proliferation of type II pneumocytes in the
thickened alveolar septum. Type II pneumocytes randomly
proliferated within the alveolar septum and did not reveal
a glandular pattern of hyperplasia which was seen in the
abscessed lungs. In the proliferated type II cells, positive

Figure 3. A high number of type II alveolar epithelial cells reveals
the cytoplasmic immunolabeling for SP-A in the abscessed lung
(ABC, Bar = 51µm).

Figure 4. Numerous type II alveolar epithelial cells proliferated
in the glandular appearance show a strong cytoplasmic immune
reaction for SP-B in the abscessed lung (ABC, Bar = 166 µm).

Figure 5. An intense proSP-C immunolabeling in the proliferated type II alveolar epithelial cells at the alveolar septum in a
lung with interstitial pneumonia (ABC, Bar = 51µm).
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staining for SP-B was clearly seen as large cytoplasmic
granules around the nuclei. However, the number of type
II cells positively stained with the SPs was fewer compared
to that of abscessed lungs showing parenchymal fibrosis.
Moreover, the intensity of immunoreaction to both SP-A
and SP-B in the cytoplasm of type II cells was slight in
comparison to that seen in the chronically affected lungs.
In both normal and less-injured regions of inflamed lungs,
a few type II cells showed a weak immunoreactivity for
all the surfactant proteins. Statistically, the number of
immunolabeled cells with SPs was highly significant (P <
0.001) between the pneumonic and control lungs.
3.3.2. Clara cell secretory protein (CCSP)
CCSP immunoreactivity in the lungs with both abscessed
lungs and interstitial pneumonia was detected in all
terminal bronchioles and in conducting airways (Figure
6). Immunoreaction occurred exclusively in the cytoplasm
of nonciliated (Clara cells) epithelial lining cells and in
some desquamated cells in the lumen of the airways. The
intensity of the immunoreaction was extremely severe in
the cytoplasm of the lining cells of bronchi than in terminal
bronchioles and was distributed throughout all the lining
cells. Bronchial lumina were often filled with immune
reaction products; therefore, the cellular details of the
lining cells could be distinguished with difficulty. Alveolar
epithelial cells did not show any staining for CCSP. The
specificity of the CCSP immunostaining was high and
allowed the identification of Clara cells among ciliated
cell clusters. Moreover, strong CCSP immunoreaction was
displayed in destructed airways and the normal structure
of the airways could not even be seen in some areas. In
distal airways, because of the strong immunoreaction,
ciliated or nonciliated Clara cells could be distinguished
with difficulty, whereas in the terminal bronchioles, Clara
cells revealed an exclusive reaction to the marker. The
sensitivity of the antibody was high and a few Clara cells
were found among the connective tissue and infiltrative
inflammatory cells. The number of the immunostained
cells was highly significant (P < 0.001) in the pneumonic
lungs compared to that in the normal lungs.
3.3.3. Thyroid transcription factor-I (TTF-I)
TTF-I immunostaining occurred exclusively in the nuclei
of type II pneumocytes and in a few Clara cells in the lungs
affected by abscessed and interstitial pneumonia. However,
a strong immunoreaction was clearly observed in the
nuclei of the proliferated type II cells around the abscessed
parenchyma (Figure 7). In the thickened alveolar septum
of the lungs with interstitial pneumonia, many round
nuclei arranged next to alveoli showed immunostaining for
TTF-I. Type II cells displaying a strong reaction to TTF-I
were noticed to be located around the interlobular septum.
However, the lining epithelial cells in the conducting
airways did not show any positive reaction to the marker.
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Figure 6. A strong immunopositive reaction to CCSP in the cytoplasm of epithelial cells in the conducting bronchi (A) and terminal bronchiole (B) (ABC, Bar=51 µm).

Figure 7. A widespread positive labeling for TTF-I in the highly
proliferated cells having round nuclei in the pneumonic lung
(ABC, Bar = 51µm).

In normal and less-affected areas of pneumonic lungs, few
type II cells revealed nuclear positivity for TTF-I marker.
Statistical analysis evaluating the number of the TTF-I
positive cells in pneumonic and normal lungs found high
significance (P < 0.001) between the groups.
3.3.4. Lamda light chain IgG (λ-IgG)
Numerous plasmacytes and B cells revealed clear
positive cytoplasmic staining for the marker. In the
abscessed lungs, λ-IgG immunopositivity was detected
particularly in the peribronchial lymphoid aggregations,
or in the inflammatory cells among the connective tissue
proliferation around the necroses. λ-IgG–immunopositive
cells were predominantly detected in the lungs affected
by chronic inflammation. Statistical analysis found high
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significance (P < 0.001) in the abscessed lungs compared
to those of other groups. The lungs affected by interstitial
pneumonia revealed a few λ-IgG–immunoreactive cells in
the interalveolar septum. The control lungs showed only
a few λ-IgG+ cells in the peribronchial lymphoid cuffings.
3.3.5. Proliferating cell nuclear antigen (PCNA)
PCNA immunolabeling occurred in the nuclei of
proliferative cells. The most prominent reaction was
seen in the peribronchial lymphoid cuffings and in
the connective tissue which surrounded necroses and
neutrophilic aggregations in abscessed lungs (Figure 8).
Additionally, numerous type II cells with round nuclei,
which proliferated with a glandular appearance, revealed
a strong nuclear reaction to PCNA. In the areas repaired
by connective tissues, numerous cells with spindle-shaped
nuclei showed a strong immune reaction. The number of
PCNA-positive cells was high in the center of peribronchial
lymphoid follicles and proliferated connective tissue cells.
In the lungs affected by interstitial pneumonia, some areas
which appeared normal and less-affected by inflammation
displayed a few PCNA-nuclear positive cells. A high
statistical significance (P < 0.001) was seen between all
groups.
3.3.6. Lymphocyte phenotypes (T and B cells)
CD3+ T cells were commonly observed in the peribronchial
lymphoid cuffings, and infrequently in the thickened
interalveolar septum of the lungs with interstitial
pneumonia. In the abscessed lungs, CD3+ T cells were
distributed around the fibrotic capsule which surrounded
necroses and pus. In acute purulent pneumonia, a few
infiltrative cells in the connective tissue around the necroses
displayed CD3+ reaction. CD79αcy+ B cells were detected
at the periphery of the BALT. In the abscessed lungs,
CD79αcy+ B cells were incorporated in the inflammatory
infiltrations. Immunoreaction was commonly cytoplasmic
and the number of positive cells was few in the lungs with
interstitial pneumonia. In normal lungs, a few lymphocytes
showed immunopositivity for both antibodies in the
BALT. Statistical analysis was not performed to evaluate
lymphocytic phenotypes as immunoreaction occurred
mainly in the BALT of both normal and pneumonic lungs.
3.4. Statistical results
In the study, the number of the immunostained-cells with
the antibodies was statistically highly significant (P <
0.001, except for λ-IgG which was P < 0.05) between the
abscessed, interstitial pneumonia, and normal lungs. All
statistical analysis results are shown in Table 2.
4. Discussion
Pulmonary inflammation occurs with a severe response
in the parenchyma and causes the destruction of alveoli
and diffuse fibrohyperplasia, consisting of fibroblasts,
capillarization, and proliferation of type II cells (14).

Figure 8. The PCNA immunopositive reaction displays severe
proliferation of fibroblasts and type II cells in a pneumonic rat
lung (ABC, Bar = 51 µm).

Our study found that pneumonic rat lungs had severe
parenchymal destruction, which resulted in alveolar
epithelization and lymphoid infiltration around the
necroses and neutrophilic infiltration, as reported in the
pneumonic lungs of sheep (15). Hyperplasia of type II
cells in the lungs of laboratory rats with pneumonia has
not been examined in detail, and literature reviews give
limited information about repair in the injured lungs
of rats. The present research focused particularly on
hyperplasia of type II cells in the abscessed lungs and
interstitial pneumonia of rats by using lung surfactant
apoproteins and found a severe proliferation of the cells
around necroses. Statistical analysis results confirmed
that the number of the immunostained-cells with SPs
was significantly high in the abscessed lungs compared to
that in the lungs affected by interstitial pneumonia and in
normal lungs. Consistent with our findings, Rhodes et al.
(16) found an evident proliferation of type II pneumocytes
and Clara cells in rat lungs experimentally infected with
Streptococcus pneumonia. It is well known that alveolar
damage begins with the degeneration and desquamation
of type I alveolar epithelial cells, following inducement
of the proliferation of type II pneumocytes and their
transformation into type I cells. This clearly confirms that
type II epithelial cells carry out the repair of damaged
alveoli and differentiate into type I cells (17). Likewise, the
ability of type I alveolar epithelial cells to divide appears
to be limited and very vulnerable to injurious agents (3).
Rhodes et al. (16) reported that the epithelial cells of the
conducting airways are able to proliferate and to replace
injured epithelial lining cells. In our study, identification
of the proliferative type II cells depended mainly on the
presence of the round nuclei, and cytoplasmic granules
supposed to be lamellar bodies immunoreacted to
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Table 2. Statistical analysis of immunohistochemical staining results.
Groups

SP-A

SP-B

Abscessed lungs

219 ± 31.55

Interstitial pneumonia

74.75 ± 3.16 a

88.37 ± 5.23 b

86 ± 6.33 b

145.25 ± 15.80 b

Normal lungs

34.13 ± 1.27 a

39.75 ± 3.01 a

36.12 ± 2.68 a

p

<0.001

<0.001

<0.001

b

292.37 ± 21.27

SP-C
c

122.12 ± 5.26

CCSP
c

141.88 ± 10.59

TTF-I
200 ± 18.93

PCNA

80.12 ± 1.80 b

181.87 ± 13.07 b

177.12 ± 12.74 b

70.75 ± 3.52 a

47.25 ± 6.35 a

72.37 ± 4.46 a

99.87 ± 3.62 a

66.75 ± 2.78 a

<0.001

<0.001

<0.001

<0.05

b

320.12 ± 15.65

λ IgG
c

b

Note: a, b, c values show statistical significance between groups for the number of immunostained-cells with the antibodies.

SP-A and SP-B, as reported by other authors (10,15,18).
Therefore, proliferation of type II cells may develop as
a response to the alveolar injury in inflammation or in
the healing phase of alveolar damage, as documented by
others (3,6,16).
SP-A–immunostained lungs revealed a predominant
cytoplasmic staining in type II cells and Clara cells.
SP-A–positive type II cells were located in the alveoli and
interalveolar septum and revealed a glandular-shaped
proliferation around the damaged regions of the lungs, as
reported in the pneumonic lungs of sheep (15). Extracellular
immunoreaction to SP-A, which was often seen as a thin
layer within the alveoli, was explained by the secretion
of SP-A into the liquid hypophase covering epithelial
cells in alveoli (5,19). It was reported that osmiophilic
lamellar vesicles of alveolar type II pneumocytes store
small quantities of SP-A (6). Following the release of
SP-A into the alveolar hypophase, a high amount of the
protein is retaken by type II cells and directed into the
lamellar vesicles for recycling (6,19). Thus, a positive SP-A
immunostaining in the cytoplasm of the type II cells is
probably dependent on the transportation of the retaken
SP-A to the lamellar vesicles. SP-A positivity was also
detected in the cytoplasm of Clara cells. SP-A is the most
commonly known apoprotein among the lung surfactants
synthesized by Clara cells. The protein has important
functions in modulating surface activity and in regulating
secretion (5,8).
It was documented that mature SP-B is stored in the
multivesicular and osmiophilic lamellar vesicles and then
directed into the alveolar lumina to make tubular myelin
(5,20). SP-B–positive labeling was found predominantly
in the glandular proliferation of type II cells around the
necroses and airways, and the reaction was found mainly
in the luminal surface of hyperplastic cells, consistent
with the findings of Brasch et al. (21). Immunolabeling of
proliferative type II cells enabled the cells to be identified
among the fibroblasts and infiltrative cells. Additionally, a
strong reaction to SP-B disclosed the enhancement of the
cytoplasmic rate of type II cells, and the apical cytoplasm
of the cells expanded into the alveolar lumina. Likewise,
Miller and Hook (3) stated that type II cell hypertrophia is
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characterized by a marked increase in the size and number
of osmiophilic lamellar vesicles. Multiple cytoplasmic
granules in the hyperplastic type II cells which evidently
showed a positive immunoreaction to the SP-B were
supposed to be characteristic osmiophilic vesicles. A
clear SP-B–positive immunoreaction also occurred in the
cytoplasm of nonciliated Clara cells. However, the ciliated
lining cells did not show any reaction to SP-A or SP-B
antibodies.
Positive staining for proSP-C was mainly found
at the periphery of the nuclei in type II cells and the
immunoreactivity was strong in the cytoplasm in the
glandular-shaped proliferation of type II cells around
the fibrotic capsule surrounding necroses. Unlike SP-A
and SP-B markers, nonciliated Clara cells did not reveal
immunolabeling for proSP-C, consistent with previously
documented findings by others in the lungs of rats (22)
and sheep (18,23,24). Type II alveolar cell hyperplasia in
the injured parenchyma confirmed the restorative capacity
of the cells in the damaged rat lungs. Some authors (21,22)
documented that both SP-A and SP-B are synthesized
by type II alveolar epithelial cells and nonciliated Clara
cells, and that proSP-C synthesis is restricted to type II
cells. Therefore, proSP-C is often used to identify type II
cells and tumors originated from this cell lineage in sheep
(18,23,24).
Clara cell secretory protein is specifically expressed from
conducting and distal airway epithelial cells in the lungs
of many mammalian species (9,10). An immunopositive
reaction to CCSP was mainly seen in the cytoplasm of the
nonciliated Clara cells of terminal bronchioles. Likewise,
Clara cells are a well-differentiated cell type with a specific
secretory activity (10). In the respiratory bronchioles,
CCSP-positive labeling was also very strong in the
cytoplasm of lining epithelial cells, with an extracellular
reaction of round molecules in the lumina of the airways.
Consistent with our results for CCSP, other authors (10,25)
previously reported a strong immunopositivity in the
cytoplasm of Clara cells throughout airways. Even though
the precise functions of CCSP could not be defined in the
pneumonic rat lungs, the protein was reported to play an
important role in the lung-inflammatory response against
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injurious agents and was established as a diagnostic tool
in rodents (9,10). Statistical analysis found no significance
for the number of CCSP-immunostained cells between
the abscessed lungs and interstitial pneumonia.
Thyroid transcription factor-I is a tissue-specific
homeodomain expressed especially from the thyroid
and lungs. Statistical analysis detected high significance
(P < 0.001) for the number of immunostained-cells with
TTF-I between pneumonic and normal lungs. In the
lungs, the protein is expressed especially from the type
II alveolar epithelial and Clara cells. Therefore, it has
often been used as a diagnostic marker to distinguish
malignant lung neoplasms from other nonpulmonary
malignancies (11,12,26,27). The present study found clear
nuclear immunopositivity for TTF-I in type II cells in
interalveolar septum from both pneumonic and normal
rat lungs, and in a few Clara cells. However, ciliated lining
epithelial cells of the conducting airways did not reveal
a positive reaction for the marker. Thus, as reported by
others (26,27), TTF-I protein may be used as a significant
diagnostic marker in differentiating tumor cells originated
from type II alveolar epithelium and thyroid cells.
A humoral immune response, represented by increased
λ-IgG positive plasmacytes in the pneumonic lungs, was
indicative of a local humoral immune response, as stated
by other authors (28). B cells and IgG-bearing plasmacyte
accumulation in the lungs might have occurred as an
immunologic response because of continuous stimulation
by infectious agents. In addition, parenchymal injury and
released autoantigens in the lungs may also indicate an
ongoing humoral immune response to an agent. However,
even if an immune response occurred in the pneumonic
lungs of rats, the raised immune response could not
prevent pneumonia with pus formation.
Proliferating cell nuclear antigen is involved in many
cellular functions and is often used in elucidating the
prognosis of tumors (29). In the present study, PCNA

was used to assess the proliferating capacity of type II
epithelial cells and fibrocytes in the restoration of the
damaged alveoli in the pneumonic rat lungs. Strong
nuclear immunopositivity for PCNA was found in the
cells with round nuclei at the glandular proliferation
and in the spindle-shaped nuclei at the fibrotic tissue.
Increased PCNA nuclear positivity evidently occurred
in the pneumonic lungs compared to the unaffected lung
areas or controls, as seen in the statistical analysis results.
Positive immunolabeled cells with round nuclei indicated
mainly proliferated type II cells. The spindle-shaped cells
with nuclear positivity were assumed to be fibroblasts
because of morphological features. The present findings
show the significant roles played by the proliferated cells
of both lineages in the restoration of damaged rat lungs.
Lymphocytic infiltration is a chronic inflammatory
reaction and is accepted as a cell-mediated nonspecific
immune response (30). In the lungs with pneumonia
and in the normal lungs of rats, lymphoid cell cuffings
were clearly detected surrounding all conducting
airways and interalveolar septum, and were more
intense in the pneumonic lungs than in the normal
lungs. Immunostaining for the lymphocytic phenotypes
disclosed increased CD3+ T cell infiltration compared
to the number of CD79αcy+ B cells in pneumonic
lungs. The infiltrative lymphocytic cells may confirm
the development of a local immune response in the
pneumonic lungs of rats.
In conclusion, the present study found that hyperplasia
of type II alveolar epithelial cells was indicative of
restoration of injured lungs in the laboratory rats. The
rat lungs affected by parenchymal necrosis resulted in
diffuse alveolar fibrosis and inflammatory cell infiltration.
Additionally, an immunoperoxidase technique using SPs
or CCSP may be a very useful tool in the identification of
neoplasms originated from type II cells and nonciliated
Clara cells, respectively.
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